Hong Kong Personal Products Stock News

As global markets navigate a period of volatility and geopolitical uncertainty, the Asian market continues to present intriguing opportunities for investors, particularly in the realm of growth companies with high insider ownership. In this environment, stocks that demonstrate robust earnings growth and strong insider commitment can offer a compelling mix of potential stability and upside, making them noteworthy considerations for those looking to understand current trends in Asia's evolving...

As global markets navigate a landscape marked by geopolitical tensions and economic shifts, Asian stocks present intriguing opportunities for investors seeking growth beyond the traditional indices. In this environment, identifying promising small-cap companies can be key to capitalizing on regional economic trends and sector-specific strengths.

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

OSL Group has issued earnings guidance indicating a net loss from continuing operations of HK$370 million to HK$430 million for FY2025, compared with a profit of about HK$55 million in FY2024, driven by higher expansion costs, fair value losses on digital assets and one-off professional fees. Despite the loss guidance, the group forecasts IFRS income from its digital assets and blockchain platform business to rise to HK$450 million–HK$530 million and adjusted non-IFRS income to HK$490...

Key Insights Aluminum Corporation of China's significant retail investors ownership suggests that the key decisions are...

Key Insights The projected fair value for Beijing Enterprises Holdings is HK$45.73 based on Dividend Discount Model...

What financial metrics can indicate to us that a company is maturing or even in decline? More often than not, we'll see...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

There wouldn't be many who think InnoCare Pharma Limited's ( HKG:9969 ) price-to-sales (or "P/S") ratio of 12.5x is...

MicroPort Scientific Corporation recently issued consolidated earnings guidance indicating that for the year ended 31 December 2025 it expects a turnaround to profitability, with net profit of at least US$20 million versus an audited net loss of about US$268 million in 2024. This projected swing from a very large loss to a positive bottom line highlights a major shift in the company’s operational and financial trajectory. We will now examine how MicroPort Scientific’s anticipated return to...

We wouldn't blame Acme International Holdings Limited ( HKG:1870 ) shareholders if they were a little worried about the...

It might be of some concern to shareholders to see the MGM China Holdings Limited ( HKG:2282 ) share price down 17% in...

Key Insights Minsheng Education Group's significant insider ownership suggests inherent interests in company's...

Those holding Modern Chinese Medicine Group Co., Ltd. ( HKG:1643 ) shares would be relieved that the share price has...

Despite an already strong run, Perfect Optronics Limited ( HKG:8311 ) shares have been powering on, with a gain of 48...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Key Insights The projected fair value for Ferretti is HK$62.04 based on 2 Stage Free Cash Flow to Equity Ferretti is...

Whilst it may not be a huge deal, we thought it was good to see that the Texwinca Holdings Limited ( HKG:321...

With a price-to-earnings (or "P/E") ratio of 19x Galaxy Entertainment Group Limited ( HKG:27 ) may be sending very...

Genscript Biotech (SEHK:1548) is back in focus after its associate Legend Biotech reported approximately US$555 million in Q4 2025 net trade sales of multiple myeloma cell therapy CARVYKTI®, underscoring meaningful commercial traction. See our latest analysis for Genscript Biotech. Legend Biotech’s CARVYKTI® sales update has arrived after a mixed year for Genscript Biotech, with the share price at HK$13.3, a year to date share price return of 3.99%, a 1 year total shareholder return of 26.19%...

Production update and why it matters for CGN Mining CGN Mining (SEHK:1164) has released unaudited natural uranium production figures, reporting 702.5 tU for the fourth quarter of 2025 and 2,699.0 tU for the full year. This provides investors with fresh insight into recent operating performance. See our latest analysis for CGN Mining. The production update lands after a strong run in the shares. The latest HK$4.3 price comes alongside a 32.72% year to date share price return and a very large 5...

As the Asian markets navigate a landscape marked by mixed economic signals, investors are keenly observing opportunities that may arise from current market fluctuations. In this environment, identifying stocks trading at an estimated discount requires a focus on companies with strong fundamentals and resilience in the face of global uncertainties.

Record profit outlook puts recent share gains in focus COSCO SHIPPING Energy Transportation (SEHK:1138) is in the spotlight after projecting record profit for 2025 and signaling strong year-on-year growth for early 2026, supported by resilient oil transport demand and constrained shipping capacity. See our latest analysis for COSCO SHIPPING Energy Transportation. Investors have responded quickly to COSCO SHIPPING Energy Transportation’s outlook, with a 30 day share price return of 33.68% and...